THE CORRELATION BETWEEN ECHOCARDIOGRAPHIC EPICARDIAL FAT THICKNESS AND CHA2DS2-VASC SCORE FOR STROKE RISK IN PATIENTS WITH SINUS RHYTHM
Main Article Content
Abstract
Background: Increased epicardial fat thickness (EFT) is associated with hypertension, insulin resistance, and thromboembolic events such as stroke, acute coronary syndrome. CHA2DS2-VASc is a common score assessing the risk of stroke and thromboembolism in patients with or without atrial fibrillation not related to valvular heart disease. Objective: To determine the correlation between echocardiographic EFT and CHA2DS2-VASc score in patients with sinus rhythm. Subjects and research method: A descriptive cross- sectional study was conducted on 260 patients with sinus rhythm hospitalized for all causes, who underwent transthoracic echocardiography at the department of Internal Medicine and Interventional Cardiology, University Medical Center Ho Chi Minh, campus 1, from October 2023 to April 2024. Results: The mean EFT in low and high CHA2DS2-VASc groups were 4,1± 1,5 mm and 6,6± 1,9 mm, respectively, with a statistically significant difference (p<0,001). There was a positive, moderate, statistically significant correlation (r=0,6; p<0,001) between EFT and CHA2DS2-VASc score. Receiver operating characteristic (ROC) analysis showed that an EFT of 5,3 mm was the optimal cut- off value for predicting the high risk according to the CHA2DS2-VASc score, with a sensitivity of 81% and specificity of 82% (Area under the curve AUC= 0,87; 95% CI: 0,82- 0,91). Conclusions: Echocardiographic epicardial fat thickness could provide additional information on assessing thromboembolic risks, and individuals with increased EFT should receive more attention to reduce unfavorable cardiovascular risk factors and the development of future cardiovascular events.
Article Details
Keywords
Epicardial fat thickness, CHA2DS2-VASc score, transthoracic echocardiography.
References
2. Guan B, Liu L, Li X, et al. Association between epicardial adipose tissue and blood pressure: A systematic review and meta-analysis. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2021;31(9): 2547-2556. doi:10.1016/j.numecd. 2021.05.009
3. Mahabadi AA, Lehmann N, Kälsch H, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovascular imaging. 2014;7(9): 909-916. doi:10.1016/j.jcmg.2014. 07.002
4. Li C, Liu X, Adhikari BK, et al. The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management. Frontiers in endocrinology. 2023;14:1167952. doi:10.3389/fendo.2023.1167952
5. Mazzone C, Cioffi G, Carriere C, et al. Predictive role of CHA(2)DS(2)-VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm. European journal of preventive cardiology. 2017;24(15): 1584-1593. doi:10.1177/ 2047487317726068
6. Siddiqi TJ, Usman MS, Shahid I, et al. Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis. European journal of preventive cardiology. 2022;29(4): 625-631. doi:10.1093/ eurjpc/zwab018
7. Akdag S, Simsek H, Sahin M, Akyol A, Duz R, Babat N. Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASASc score in patients with nonvalvular atrial fibrillation. Therapeutics and clinical risk management. 2015;11:1675-1681. doi:10.2147/tcrm.s94955
8. Eroğlu S. How do we measure epicardial adipose tissue thickness by transthoracic echocardiography? Anatolian journal of cardiology. 2015;15(5):416-419. doi:10.5152/akd. 2015.5991